BMRN - Biomarin Pharmaceutical Inc.

Across the last three months, Biomarin Pharmaceutical Inc.'s insiders have reduced their positions by a net 17,557 shares worth roughly $1.2M.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Alexander Hardy	214.6K	$11.95M	-
CFO	Brian Mueller	123.3K	$6.86M	-
VP	Charles Greg Guyer	84.1K	$4.68M	-
VP	George Eric Davis	61.0K	$3.40M	-
Dir	Robert J. Hombach	49.4K	$2.75M	-

Buys and sells only

10 filings · page 20

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jun 22, 2018	Robert Baffi	EVP, Technical Operations	Sale+OE	6,949	$99.00	$687,954.28	-7.7%
Jun 22, 2018	Daniel K Spiegelman59	EVP, Chief Financial Officer	Sell	10,000	$99.00	$990,004.72	-16.4%
Jun 15, 2018	Brian Mueller64	SVP, Corporate Controller	Sell	2,021	$94.50	$190,984.50	-13.4%
Jun 14, 2018	Henry J Fuchs	President, Worldwide R& D	Sale+OE	31,000	$90.00	$2,790,084.79	-16.7%
Jun 11, 2018	Jeffrey Robert Ajer58	EVP, Chief Commercial Officer	Sell	1,436	$90.31	$129,685.16	-2.8%
May 17, 2018	Jean Jacques Bienaime68	Chief Executive Officer	Sale+OE	18,750	$88.66	$1,662,356.25	-6.1%
May 16, 2018	Jean Jacques Bienaime68	Chief Executive Officer	Sale+OE	18,750	$89.13	$1,671,131.25	-6.1%
May 15, 2018	Jean Jacques Bienaime68	Chief Executive Officer	Sale+OE	37,500	$88.75	$3,328,284.38	-11.4%
May 11, 2018	Jean Jacques Bienaime68	Chief Executive Officer	Sale+OE	37,500	$89.00	$3,337,650.00	-11.4%
May 10, 2018	Brian Mueller64	SVP, Corporate Controller	Sell	2,450	$89.50	$219,275.00	-13.7%